Related Experiment Video
Updated: Aug 5, 2026
08:32
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
Hematopoietic stem cell transplantation and cellular therapy
H-J Kolb1,2,3,4
1Helmholtz Zentrum Muenchen, Muenchen, Germany.
HLA
|April 4, 2017
Summary
Allogeneic stem cell transplants improve survival for leukemia patients but face challenges like graft-vs-host disease (GVHD). Strategies are explored to enhance the graft-vs-leukemia (GVL) effect while minimizing GVHD for better outcomes.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Allogeneic stem cell transplantation (allo-SCT) offers a survival advantage for patients with relapsed or high-risk leukemia.
- Graft-vs-host disease (GVHD) and infections are significant complications following allo-SCT.
- T-cell depletion, a strategy to prevent GVHD, can lead to graft rejection, delayed immune reconstitution, and increased relapse rates.
Purpose of the Study:
- To review factors influencing GVHD in allo-SCT.
- To explore strategies for separating the graft-vs-leukemia (GVL) effect from GVHD.
- To discuss the role of cellular therapies in improving allo-SCT outcomes.
Main Methods:
- Review of current literature on GVHD prophylaxis and GVL enhancement.
- Analysis of advances in histocompatibility, chimerism, and tolerance.
- Evaluation of cellular therapies, including donor lymphocyte infusions (DLI).
Main Results:
- GVHD remains a major challenge in allo-SCT, impacting vital organs.
- T-cell depletion strategies for GVHD prophylaxis have drawbacks, including increased relapse risk.
- Separating GVL from GVHD is crucial for optimizing allo-SCT efficacy.
Conclusions:
- Further research into histocompatibility, chimerism, and tolerance is needed to foster GVL over GVHD.
- Cellular therapies, such as DLI, show promise for disease control post-transplant.
- Optimizing allo-SCT requires balancing the benefits of immune-mediated anti-leukemia effects with the risks of GVHD.
Related Concept Videos
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...